DSDiego Segura-Rodríguez

Diego Segura-Rodríguez

*This is an algorithmically generated author record based on publicly available information.

Diego Segura-Rodríguez has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Lymphatic System in the Fontan Circulation: Pathophysiology, Imaging and Therapeutic Interventions

    by Cristina Cánovas-Galindo, Diego Segura-Rodríguez, Raquel Ladrón-Abia, Eduardo Moreno-Escobar


  • Open Access

    Flow dynamics and systemic arterial stiffness distinguish bicuspid aortic valve aortopathy from heritable thoracic aortic disease

    by Diego Segura-Rodríguez, Miguel Morales-García, Eduardo Moreno-Escobar, Pilar Martín de la Fuente, Francisco Burillo Gómez, José Antonio Miras-Ventura, Elvira Pérez Cuenca, Inés Uribe, Rocío García-Orta

    Aims: Bicuspid aortic valve-associated aortopathy (BAVA) and heritable thoracic aortic disease (HTAD) share clinical manifestations but may represent distinct pathophysiological entities. We aimed to compare morphological and haemodynamic profiles between both groups using cardiovascular magnetic resonance (CMR) imaging and non-invasive systemic haemodynamic assessment. Methods and results: A total of 185 patients (111 BAVA, 74 HTAD) were prospectively enrolled. CMR 4D-flow assessed aortic distensibility (ADCMR), pulse wave velocity (PWVCMR), global wall shear stress (WSSCMR), and energy loss (ELCMR). Oscillometry assessed systemic PWVM, augmentation index (AIxM), and systemic vascular resistance (SVRM). Composite adverse aortic events (AAEs) comprised acute aortic syndrome, cardiovascular death, or guideline diameter-based indication for surgery over 42.1 ± 17.6 months. BAVA showed greater tubular ascending aorta and sinotubular junction dilation, ascending aorta WSSCMR (0.42 ± 0.18 vs. 0.28 ± 0.12 Pa, P = 0.020), ELCMR (19.8 ± 8.4 vs. 12.3 ± 6.1 mW, P < 0.001), and ADCMR (6.1 ± 3.5 vs. 4.8 ± 2.9 × 10⁻³ mmHg⁻¹, P = 0.023), yet lower systemic stiffness than HTAD (PWVM 6.2 ± 1.7 vs. 7.8 ± 2.1 m/s; AIxM 12.1 ± 7.6 vs. 18.4 ± 9.2%; both P < 0.001). AAE rates were similar. In exploratory aetiology-specific analyses, ascending aorta WSSCMR was associated with events in BAVA (HR 8.92, 95% CI 2.85–27.95) and systemic PWVM in HTAD (HR 2.16, 95% CI 1.30–3.57). Conclusion: BAVA and HTAD show distinct morphological and haemodynamic phenotypes: BAVA with focal dilation, elevated WSSCMR/ELCMR and preserved systemic function; HTAD with reduced local distensibility and greater systemic stiffness. These aetiology-specific predictors are exploratory and require external validation.

  • Papel del ecógrafo de bolsillo en la exploración cardiovascular multidisciplinar. Revisión del estado actual

    by Diego Segura-Rodríguez, Clara Bonanad, Elena Fortuny, Ángel Prades-Sánchez, Román Freixa-Pamias, Sergio Raposeiras-Roubín, David Vivas Balcones

  • Open Access

    Predictors and outcomes of pulmonary hypertension after mitral valve replacement in severe mitral regurgitation

    by García-Orta Rocío, González Molina Mercedes, Uribe Morales Inés, Torres Quintero Lucía, Rodríguez Torres Diego J., Segura Rodríguez Diego, Moreno Escobar Eduardo

    Background: The objective of the study was to determine perioperative clinical and echocardiographic factors associated with pulmonary hypertension (PH) during long-term follow-up of patients with severe primary mitral regurgitation (MR) after mitral valve replacement surgery and its prognostic repercussions. Methods: Prospective cohort of consecutive patients undergoing mitral valve replacement between January 2005 and January 2015 and followed for ≥3 years. Main exclusion criteria were receipt of mitral repair surgery and the presence of mitral stenosis. The main outcome was a systolic pulmonary pressure (SPAP) by echocardiography >50 mmHg at least 12 months’ post-surgery. Results: 106 patients, 46% male, mean age of 61.7±11 yrs. and median follow-up of 8.8 [6- 16] yrs. SPAP was >50 mmHg in 33% of patients. Predictors identified by multivariate analysis were diabetes (OR 8.3, 95%CI 1.1-73.9), persistent atrial fibrillation (OR 4.2, 95%CI 1.1-20.6), non-rheumatic MR (OR 7.3, 95%CI 1.1-45.5), prosthesis gradient, (OR 2.8, 95%CI 1.3-5.7), patient-prosthesis mismatch (OR 16.9, 95%CI 1.2-234), and preoperative SPAP ≥50 mmHg (OR 19.3, 95%CI 3.4-107). Patients with PH had higher hospitalization (78.8 % vs. 37%, pversus 30% in those with PH (p<0.001). Conclusions: Persistent PH is a frequent and serious long-term complication of valve replacement for severe mitral regurgitation. It is associated with a poor prognosis and is related to preoperative pulmonary pressure. Surgery could be considered in candidates for mitral valve replacement with moderate PH, especially in the presence of atrial fibrillation. Clinical perspective: What is already known on this topic: Pulmonary hypertension is not reversed in an important subset of patients with severe mitral regurgitation after mitral valve replacement surgery and it is associated with a poor prognosis. No prospective study has been published on preoperative factors associated with this condition. The prevalence and prognosis of postoperative PH has not been precisely described. What this study adds: Persistent PH after valve replacement for severe mitral regurgitation is common and its prognosis is ominous. Preoperative SPAP ≥50 mmHg and persistent atrial fibrillation are the main predictive factors. The results of this study might affect clinical practice suggesting considering surgery in this population (not only in mitral valve repair) when SPAP ≥50 mmHg, especially if persistent atrial fibrillation. Graphical

  • Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype–phenotype correlation study

    by Diego Segura-Rodríguez, Francisco José Bermúdez-Jiménez, Víctor Carriel, Silvia López-Fernández, Mercedes González-Molina, José Manuel Oyonarte Ramírez, Laura Fernández-Navarro, María Dolores García-Roa, Elisa M Cabrerizo, Daniel Durand-Herrera, et al.

    Aims: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. Cardiac magnetic resonance (CMR) imaging can identify fibrofatty scar by late gadolinium enhancement (LGE). Our aim is to investigate genotype–phenotype correlation in ARVC/D mutation carriers, focusing on CMR-LGE and myocardial fibrosis patterns. Methods and results: A cohort of 44 genotyped patients, 33 with definite and 11 with borderline ARVC/D diagnosis, was characterized using CMR and divided into groups according to their genetic condition (desmosomal, non-desmosomal mutation, or negative). We collected information on cardiac volumes and function, as well as LGE pattern and extension. In addition, available ventricular myocardium samples from patients with pathogenic gene mutations were histopathologically analysed. Half of the patients were women, with a mean age of 41.6 ± 17.5 years. Next-generation sequencing identified a potential pathogenic mutation in 71.4% of the probands. The phenotype varied according to genetic status, with non-desmosomal male patients showing lower left ventricular (LV) systolic function. LV fibrosis was similar between groups, but distribution in non-desmosomal patients was frequently located at the posterolateral LV wall; a characteristic LV subepicardial circumferential LGE pattern was significantly associated with ARVC/D caused by desmin mutation. Histological analysis showed increased fibrillar connective tissue and intercellular space in all the samples. Conclusion: Desmosomal and non-desmosomal mutation carriers showed different morphofunctional features but similar LV LGE presence. DES mutation carriers can be identified by a specific and extensive LV subepicardial circumferential LGE pattern. Further studies should investigate the specificity of LGE in ARVC/D.


  • Recanalisation of subclavian-pulmonary artery shunt in adult with tetralogy of Fallot

    by Eduardo Moreno Escobar, Diego Segura-Rodriguez, Diego José Rodriguez Torres, Rocio Garcia Orta

    We report the case of a patient diagnosed with extreme tetralogy of Fallot who received subclavian-pulmonary artery shunt at the age of 3 years and underwent corrective surgery at the age of 16 years. The patient developed progressive effort dyspnea and left ventricular dysfunction from the age of 40 years. The exploratory finding of a continuous jugular and left subclavian murmur prompted an echocardiographic study that evidenced a continuous flow in the suprasternal view. CT study confirmed the patency of the surgical subclavian-pulmonary artery shunt, which was percutaneously embolised with the implantation of an Amplatzer plug, with a good final outcome and no residual flow. The patient showed a satisfactory development with clinical improvement, decreased left ventricular volume and enhanced left ventricular function.

  • Oclusión venosa pulmonar como complicación del tratamiento ablativo de la fibrilación auricular

    by Laura Fernández-Navarro, Elena Moya-Sánchez, Diego Segura-Rodríguez, Eduardo Ruiz-Carazo


  • Una variante rara del síndrome de la cimitarra

    by Diego José Rodríguez-Torres, Diego Segura-Rodríguez, Rocío García-Orta